Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Wu, Tao ^a   Zhang, Zhigang ^b   Liu, Bin ^a   Hou, Dezhi ^a   Liang, Yun ^a   Zhang, Jie ^a   Shi, Peng ^b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Bacterial colonization; Bile; Cholesterol gallstone; Gut microbiota dysbiosis; Pyrosequencing

Indexed keywords

BACTERIAL RNA; RNA 16S; CHOLESTEROL;

ADULT; ARTICLE; BACTERIAL GENE; BACTEROIDES VULGATUS; BG GENE; BILE; BILIARY TRACT MICROBIOTA; BSH GENE; CHOLESTEROL STONE; CLINICAL ARTICLE; CONTROLLED STUDY; FAECALIBACTERIUM; FEMALE; GALLSTONE; GASTROINTESTINAL DISEASE; GENE; GUT MICROBIOTA DYSBIOSIS; HEPATOBILIARY SYSTEM; HUMAN; INTESTINE FLORA; LACHNOSPIRA; LACHNOSPIRACEAE; MALE; MDR GENE; MICROBIAL COMMUNITY; MICROBIOME; PHL GENE; PROPIONIBACTERIUM ACNES; PROTEOBACTERIA; PSEUDOMONAS PUTIDA; RNA SEQUENCE; ROSEBURIA; BACTERIA; DYSBIOSIS; GASTROINTESTINAL TRACT; METABOLISM; METAGENOMICS; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; PHYLOGENY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); BACTEROIDES; FAECALIBACTERIUM; LACHNOSPIRA; OTUS; PROPIONIBACTERIUM ACNES; PROTEOBACTERIA; PSEUDOMONAS PUTIDA; ROSEBURIA;

BACTERIA; BILIARY TRACT; CHOLESTEROL; DYSBIOSIS; FEMALE; GALLSTONES; GASTROINTESTINAL TRACT; HUMANS; MALE; METAGENOMICS; MICROBIOTA; MIDDLE AGED; PHYLOGENY;

EID: 84884777272     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-669     Document Type: Article

References (74)

1. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006, 368(9531):230-239. 10.1016/S0140-6736(06)69044-2, 16844493.
2. Wang DQ-H, Cohen DE, Carey MC. Biliary lipids and cholesterol gallstone disease. J Lipid Res 2009, 50(Supplement):S406-S411. 2674701, 19017613.
3. Van Erpecum KJ, Van Berge-Henegouwen GP. Gallstones: an intestinal disease?. Gut 1999, 44(3):435-438. 10.1136/gut.44.3.435, 1727410, 10026334.
4. Sayin Sama I, Wahlström A, Felin J, Jäntti S, Marschall H-U, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013, 17(2):225-235. 10.1016/j.cmet.2013.01.003, 23395169.
5. Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010, 90(3):859-904. 10.1152/physrev.00045.2009, 20664075.
6. Capoor MR. Microflora of bile aspirates in patients with acute cholecystitis with or without cholelithiasis: a tropical experience. Braz J Infect Dis 2008, 12:222-225.
7. Abeysuriya VDK, Wijesuriya T, Salgado SS. Microbiology of gallbladder bile in uncomplicated symptomatic cholelithiasis. Hepatobiliary Pancreat Dis Int 2008, 7(6):633-637.
8. White JS, Hoper M, Parks RW, Clements WDB, Diamond T. Patterns of bacterial translocation in experimental biliary obstruction. J Surg Res 2006, 132(1):80-84. 10.1016/j.jss.2005.07.026, 16154151.
9. Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?. Obes Rev 2011, 12(4):272-281. 10.1111/j.1467-789X.2010.00797.x, 20804522.
10. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482(7384):179-185. 3276682, 22297845.
11. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464(7285):59-65. 10.1038/nature08821, 3779803, 20203603.
12. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490(7418):55-60. 10.1038/nature11450, 23023125.
13. Zhang Z, Zhai H, Geng J, Yu R, Ren H, Fan H, Shi P. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am J Gastroenterol 2013, DOI: 10.1038/ajg.2013.221.
14. Maki T. Pathogenesis of calcium bilirubinate gallstone: role of E. coli, beta-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann Surg 1966, 164(1):90-100. 10.1097/00000658-196607000-00010, 1477184, 5329901.
15. Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, Carey MC, Fox JG. Identification of cholelithogenic enterohepatic Helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 2005, 128(4):1023-1033. 10.1053/j.gastro.2005.01.008, 15825083.
16. Julka K, Ko CW. Infectious diseases and the gallbladder. Infect Dis Clin N Am 2010, 24(4):885-898.
17. Alexander S, Wolfgang L, Hartmut P, Friedrich P. Molecular genetic evidence of bacterial colonization of cholesterol gallstones. Gastroenterology 1995, 108(3):860-864. 10.1016/0016-5085(95)90461-1, 7875489.
18. Kaufman HS, Magnuson TH, Lillemoe KD, Frasca P, Pitt HA. The role of bacteria in gallbladder and common duct stone formation. Ann Surg 1989, 209(5):584-591. discussion 591-582, 10.1097/00000658-198905000-00011, 1494083, 2705823.
19. Lee DK, Tarr PI, Haigh WG, Lee SP. Bacterial DNA in mixed cholesterol gallstones. Am J Gastroenterol 1999, 94(12):3502-3506. 10.1111/j.1572-0241.1999.01614.x, 10606311.
20. Hazrah P, Oahn KT, Tewari M, Pandey AK, Kumar K, Mohapatra TM, Shukla HS. The frequency of live bacteria in gallstones. HPB (Oxford) 2004, 6(1):28-32.
21. Kawai M, Iwahashi M, Uchiyama K, Ochiai M, Tanimura H, Yamaue H. Gram-positive cocci are associated with the formation of completely pure cholesterol stones. Am J Gastroenterol 2002, 97(1):83-88. 10.1111/j.1572-0241.2002.05425.x, 11808974.
22. Swidsinski A, Khilkin M, Pahlig H, Swidsinski S, Priem F. Time dependent changes in the concentration and type of bacterial sequences found in cholesterol gallstones. Hepatology 1998, 27(3):662-665. 10.1002/hep.510270304, 9500691.
23. Monstein H-J, Jonsson Y, Zdolsek J, Svanvik J. Identification of Helicobacter pylori DNA in human cholesterol gallstones. Scand J Gastroentero 2002, 37(1):112-119.
24. Cariati A, Cetta F. Re: Kawai et al. [mdash] bacteria are not important in the formation of pure cholesterol stones. Am J Gastroenterol 2002, 97(11):2921-2922.
25. Swidsinski A, Schlien P, Pernthaler A, Gottschalk U, Bärlehner E, Decker G, Swidsinski S, Strassburg J, Loening-Baucke V, Hoffmann U, et al. Bacterial biofilm within diseased pancreatic and biliary tracts. Gut 2005, 54(3):388-395. 10.1136/gut.2004.043059, 1774423, 15710988.
26. Piddock LJV. Multidrug-resistance efflux pumps ? not just for resistance. Nat Rev Micro 2006, 4(8):629-636.
27. Lin J, Sahin O, Michel LO, Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 2003, 71(8):4250-4259. 10.1128/IAI.71.8.4250-4259.2003, 165992, 12874300.
28. Kullak-ublick GA, Stieger B, Meier PJ. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 2004, 126(1):322-342. 10.1053/j.gastro.2003.06.005, 14699511.
29. Begley M, Gahan CGM, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005, 29(4):625-651. 10.1016/j.femsre.2004.09.003, 16102595.
30. Glavinas H, Krajcsi P, Cserepes J, Sarkadi B. The role of ABC transporters in drug resistance, metabolism and toxicity. Current drug delivery 2004, 1(1):27-42. 10.2174/1567201043480036, 16305368.
31. Lin J, Michel LO, Zhang Q. CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother 2002, 46(7):2124-2131. 10.1128/AAC.46.7.2124-2131.2002, 127319, 12069964.
32. Pumbwe L, Randall LP, Woodward MJ, Piddock LJV. Expression of the efflux pump genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. J Antimicrob Chemother 2004, 54(2):341-347. 10.1093/jac/dkh331, 15201231.
33. Cahalane MJ, Neubrand MW, Carey MC. Physical-chemical pathogenesis of pigment gallstones. Semin Liver Dis 1988, 8(4):317-328. 10.1055/s-2008-1040553, 3062787.
34. Stewart L, Grifiss JM, Jarvis GA, Way LW. Biliary bacterial factors determine the path of gallstone formation. Am J Surg 2006, 192(5):598-603. 10.1016/j.amjsurg.2006.08.001, 17071191.
35. Belzer C, Kusters JG, Kuipers EJ, van Vliet AHM. Urease induced calcium precipitation by Helicobacter species may initiate gallstone formation. Gut 2006, 55(11):1678-1679. 10.1136/gut.2006.098319, 1860090, 17047128.
36. Csendes A, Becerra M, Burdiles P, Demian I, Bancalari K, Csendes P. Bacteriological studies of bile from the gallbladder in patients with carcinoma of the gallbladder, cholelithiasis, common bile duct stones and no gallstones disease. Eur J Surg 1994, 160(6-7):363-367.
37. Zoetendal EG, von Wright A, Vilpponen-Salmela T, Ben-Amor K, Akkermans ADL, de Vos WM. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002, 68(7):3401-3407. 10.1128/AEM.68.7.3401-3407.2002, 126800, 12089021.
38. Kuczynski J, Lauber CL, Walters WA, Parfrey LW, Clemente JC, Gevers D, Knight R. Experimental and analytical tools for studying the human microbiome. Nat Rev Genet 2012, 13(1):47-58.
39. Marschall HU, Einarsson C. Gallstone disease. J Intern Med 2007, 261(6):529-542. 10.1111/j.1365-2796.2007.01783.x, 17547709.
40. Turnbaugh PJ, Quince C, Faith JJ, McHardy AC, Yatsunenko T, Niazi F, Affourtit J, Egholm M, Henrissat B, Knight R, et al. Organismal, genetic, and transcriptional variation in the deeply sequenced gut microbiomes of identical twins. Proc Natl Acad Sci USA 2010, 107(16):7503-7508. 10.1073/pnas.1002355107, 2867707, 20363958.
41. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science 2005, 308(5728):1635-1638. 10.1126/science.1110591, 1395357, 15831718.
42. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science 2009, 326:1694-1697. 10.1126/science.1177486, 3602444, 19892944.
43. Shade A, Handelsman J. Beyond the Venn diagram: the hunt for a core microbiome. Environ Microbiol 2012, 14(1):4-12. 10.1111/j.1462-2920.2011.02585.x, 22004523.
44. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto J-M, et al. Enterotypes of the human gut microbiome. Nature 2011, 473(7346):174-180. 10.1038/nature09944, 3728647, 21508958.
45. Geng J, Fan H, Tang X, Zhai H, Zhang Z. Diversified pattern of the human colorectal cancer microbiome. Gut Pathogens 2013, 5(1):2. 10.1186/1757-4749-5-2, 3599420, 23497613.
46. Karch H, Denamur E, Dobrindt U, Finlay BB, Hengge R, Johannes L, Ron EZ, Tønjum T, Sansonetti PJ, Vicente M. The enemy within us: lessons from the 2011 European Escherichia coli O104:H4 outbreak. EMBO Mol Med 2012, 4(9):841-848. 10.1002/emmm.201201662, 3491817, 22927122.
47. Joossens M, Huys G, Cnockaert M, De Preter V, Verbeke K, Rutgeerts P, Vandamme P, Vermeire S. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011, 60(5):631-637. 10.1136/gut.2010.223263, 21209126.
48. Ramirez-Farias C, Slezak K, Fuller Z, Duncan A, Holtrop G, Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Brit J Nutr 2009, 101(4):541-550.
49. Scott KP, Martin JC, Chassard C, Clerget M, Potrykus J, Campbell G, Mayer C-D, Young P, Rucklidge G, Ramsay AG, et al. Substrate-driven gene expression in Roseburia inulinivorans: importance of inducible enzymes in the utilization of inulin and starch. Proc Natl Acad Sci USA 2011, 108(Supplement 1):4672-4679. 3063597, 20679207.
50. Rode LM, Genthner BRS, Bryant MP. Syntrophic association by cocultures of the methanol- and CO2-H2-utilizing species Eubacterium limosum and pectin-fermenting Lachnospira multiparus during growth in a pectin medium. Appl Environ Microbiol 1981, 42(1):20-22. 243954, 16345811.
51. Cryan EMJ, Falkiner FR, Mulvihill TE, Keane CT, Keeling PWN. Pseudomonas aeruginosa cross-infection following endoscopic retrograde cholangiopancreatography. J Hosp Infect 1984, 5(4):371-376. 10.1016/0195-6701(84)90004-5, 6085091.
52. Kosowski K, Karczewska E, Kasprowicz A, Andziak J, Heczko P. Bacteria in bile of patients with bile duct inflammation. Eur J Clin Microbiol 1987, 6(5):575-578. 10.1007/BF02014251, 3436318.
53. Cetta F. The role of bacteria in pigment gallstone disease. Ann Surg 1991, 213(4):315-326. 10.1097/00000658-199104000-00006, 1358350, 2009013.
54. Kawaguchi M, Saito T, Ohno H, Midorikawa S, Sanji T, Handa Y, Morita S, Yoshida H, Tsurui M, Misaka R, et al. Bacteria closely resembling Helicobacter pylori detected immunohistologically and genetically in resected gallbladder mucosa. J Gastroenterol 1996, 31(2):294-298. 10.1007/BF02389534, 8680555.
55. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, Paster BJ, Ericson RL, Lau CN, Correa P, Araya JC, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from chileans with chronic cholecystitis. Gastroenterology 1998, 114(4):755-763. 10.1016/S0016-5085(98)70589-X, 9516396.
56. Abayli B, Colakoglu S, Serin M, Erdogan S, Isiksal YF, Tuncer I, Koksal F, Demiryurek H. Helicobacter pylori in the etiology of cholesterol gallstones. J Clin Gastroenterol 2005, 39(2):134-137.
57. Maurer KJ, Rogers AB, Ge Z, Wiese AJ, Carey MC, Fox JG. Helicobacter pylori and cholesterol gallstone formation in C57L/J mice: a prospective study. Am J Physiol Gastrointest Liver Physiol 2006, 290(1):G175-G182.
58. Yucebilgili K, Mehmetoglu T, Gucin Z, Salih BA. Helicobacter pylori DNA in gallbladder tissue of patients with cholelithiasis and cholecystitis. J Infect Dev Ctries 2009, 3:856-859.
59. Karagin PH, Stenram U, Wadstrom T, Ljungh A. Helicobacter species and common gut bacterial DNA in gallbladder with cholecystitis. World J Gastroenterol 2010, 16(38):4817-4822. 10.3748/wjg.v16.i38.4817, 2955251, 20939110.
60. Tabata M, Nakayama F. Bacteria and gallstones. Digest Dis Sci 1981, 26(3):218-224. 10.1007/BF01391633, 7238247.
61. Zhang Z-G, Ye Z-Q, Yu L, Shi P. Phylogenomic reconstruction of lactic acid bacteria: an update. BMC Evol Biol 2011, 11(1):1. 10.1186/1471-2148-11-1, 3024227, 21194491.
62. De Smet I, Van Hoorde L, Vande Woestyne M, Christiaens H, Verstraete W. Significance of bile salt hydrolytic activities of lactobacilli. J Appl Microbiol 1995, 79(3):292-301.
63. Jones BV, Begley M, Hill C, Gahan CGM, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci USA 2008, 105(36):13580-13585. 10.1073/pnas.0804437105, 2533232, 18757757.
64. Crawford RW, Rosales-Reyes R, Ramírez-Aguilar ML, Chapa-Azuela O, Alpuche-Aranda C, Gunn JS. Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage. Proc Natl Acad Sci USA 2010, 107(9):4353-4358. 10.1073/pnas.1000862107, 2840110, 20176950.
65. Mazer NA, Carey MC. Quasi-elastic light-scattering studies of aqueous biliary lipid systems. Cholesterol solubilization and precipitation in model bile solutions. Biochemistry 1983, 22(2):426-442. 10.1021/bi00271a029, 6824637.
66. Wang DQ, Carey MC. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems. J Lipid Res 1996, 37(3):606-630.
67. Somjen GJ, Gilat T. A non-micellar mode of cholesterol transport in human bile. FEBS Lett 1983, 156(2):265-268. 10.1016/0014-5793(83)80510-9, 6852259.
68. Moschetta A, van Berge-Henegouwen GP, Portincasa P, Palasciano G, van Erpecum KJ. Cholesterol crystallization in model biles: effects of bile salt and phospholipid species composition. J Lipid Res 2001, 42(8):1273-1281.
69. Sunami Y, Tazuma S, Chayama K. Is a role of phospholipase A2 in cholesterol gallstone formation phospholipid species-dependent?. BBA-Mol Cell Biol L 2001, 1532(1-2):51-59.
70. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 2010, 7(5):335-336. 10.1038/nmeth.f.303, 3156573, 20383131.
71. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007, 73(16):5261-5267. 10.1128/AEM.00062-07, 1950982, 17586664.
72. Lozupone CA, Hamady M, Kelley ST, Knight R. Quantitative and qualitative β diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol 2007, 73(5):1576-1585. 10.1128/AEM.01996-06, 1828774, 17220268.
73. Arndt D, Xia J, Liu Y, Zhou Y, Guo AC, Cruz JA, Sinelnikov I, Budwill K, Nesbø CL, Wishart DS. METAGENassist: a comprehensive web server for comparative metagenomics. Nucleic Acids Res 2012, 40(W1):W88-W95. 10.1093/nar/gks497, 3394294, 22645318.
74. Siedel J, Hägele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983, 29(6):1075-1080.